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Abstract We studied rheumatoid arthritis (RA) patients
with foot complaints to address the associations between
clinical signs and symptoms, radiographic changes, and
function in connection with disease duration. Secondly, we
describe the contribution of several foot segments to the
clinical presentation and function. In 30 RA patients with
complaints of their feet, attributed to either signs of arthritis
and/or radiographic damage, we compared radiographic,
ultrasound, clinical, and functional parameters of the feet
and ankle. Pain and swelling of the ankle were correlated
weakly but statistically significantly with limitation and
disability (0.273 to 0.293) as measured on the 5-Foot
Function Index (FFI). The clinical signs of the forefoot
joints did not influence any of the functional outcome
measures. Radiographic scores for both forefeet (SvdH) and
hindfeet (Larsen) were correlated with the total Health
Assessment Questionnaire Disability Index (HAQ DI) and
the 5-FFI limitation subscale. Pain and disease duration,
more than radiographic damage, influence the total HAQ
DI significantly. With the progression of time, structural
damage and function of the rheumatic foot worsen in RA
patients. Pain and swelling of the ankle contribute more to
disability than radiographic damage of the foot and ankle.
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Introduction
In rheumatic conditions, especially rheumatoid arthritis (RA),
signs and symptoms of the feet are common. The majority of
RA patients present with arthritis of the feet and 20% of them
have radiographicdamage at the time of diagnosis [1]. In RA,
both forefoot and hindfoot involvement is associated with
disease duration and lead to severe impairment and disability
[2, 3]. After 6 years of disease duration, up to 50% of the
patients have considerable radiographic damage in the ankle
and the tarsus [4]. Despite the extent of the problem, the
rheumatoid foot is neglected. Although in the last few years
some scientific interest has arisen, there is still limited
interest in the foot in RA in the clinic possibly causing under
treatment [1]. In this study, we examined patients suffering
from RA and common foot complaints to investigate the
associations between clinical signs and symptoms, structural
damage, and function in connection with disease duration.
Secondly, we explored the contribution of several foot
segments to the clinical presentation and function.
Patients and methods
We performed a cross-sectional observational study. Thirty
consecutive RA patients of the outpatient clinic of the
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patients had signs or symptoms of arthritis and/or radio-
graphic damage of the feet or ankles due to RA. They had
to meet the 1987 ACR criteria for RA. The local ethical
committee approved this study and a written informed
consent was obtained from each patient.
The following demographic and clinical variables were
collected: age, sex, disease duration, total number of used
DMARDS, rheumatoid factor DAS 28 [5], and painful or
swollen joints in the foot.
All patients underwent ultrasound investigation of the
feet and ankles to measure synovitis (0 to 3), effusion (0 to
3), and power Doppler (PDUS) signals (0 to 3) according to
the method described by Szkudlarek [6]. The following
joints were examined: the tibiotalar joint, the subtalar joint,
the talonavicular joint, and the five metatarsophalangeals
(MTPs). An experienced rheumatologist, who had under-
taken specific postgraduate training in ultrasonography,
performed the ultrasound investigation on a Logic 9 (GE)
with a 9–13 MHz linear probe. To simplify the analysis, a
total PDUS score was calculated for the MTPs as well as
for the hindfoot joints by adding up the PDUS of the
individual joints. This was also done for total synovitis,
total effusion, and total erosion score.
To assess radiological structural damage, two experi-
enced readers (WD, HB) read the radiographs of the feet.
According to the method, Sharp/van der Heijde, each
side of the MTP or IP joint was scored for erosions from
0 to 5 with a maximum of 10 for both sides of the joint,
and for joint space narrowing from 0 to 4 with a
maximum of 4 per joint. For the total Sharp/van der
Heijde score, the erosions and joint space narrowing
scores were added. The maximum total score for both
feet adds up to 168 [7].
In addition, we read the tibiotalar joint, the subtalar joint,
and the talonavicular joint following the Larsen method, in
which erosions and joint space narrowing as well as other
signs of inflammation are expressed in one score with a
range from 0 (normal) to 5 (total mutilation of the joint).
The scoring is based on the comparison with the standard
film series as described by Larsen [8].
In each patient, we measured the Joint Alignment and
Motion (JAM) scale of feet and ankle according to the
description of Spiegel et al. [9]. It consists of a five-point
scale for each joint. A score of 0 represents a normal range
of motion (ROM) and alignment, a score of 1, a 0% to 5%
decrease in ROM or malalignment, a score of 2, a 6% to
25% decrease in ROM or mild malalignment, a score of 3,
a 26% to75% decrease in ROM or joint subluxation, and a
score of 4, a 76% to 100% decrease in ROM or joint fusion
or joint dislocation. The JAM score for an individual joint
represents the most severe or limiting aspect of either
motion or alignment.
Function was measured by the following variables:
Health Assessment Questionnaire (HAQ), Arthritis Impact
Measurement Scales (AIMS), and 5-Foot Function Index
(5-FFI). The HAQ has been developed by Fries et al. and
was adapted for the Dutch population [10]. The question-
naire consists of eight categories, which represent the
activities of daily living, and for each category, there are
two to four questions. The responses are scored on a four-
point scale: 0 without difficulty; 1 with some difficulty; 2
with difficulty; and 3 impossible. The questionnaire has a
final column in which respondents can indicate the use of
any aid or device. The use of any of these devices is scored
by at least a 2. The highest score for each of the eight
categories is taken as the score for that category. The final
score of the questionnaire is the averaged score of all the
categories and ranges between 0 and 3.
The AIMS score is a widely used instrument and has
been adapted and validated for the Dutch language and
culture [11]. The score consists of 77 items divided into 12
scales. These 12 scales can be combined into five
components: physical health, psychological health, symp-
toms, social interaction, and work. The scales vary from 0
(good health) to 10 (bad health). The components for
psychological health and social interaction and work were
used to describe psychosocial functioning.
The 5-FFI is a self-administered index consisting of 23
items divided into three scales (Limitation, Pain, and
Disability). We used the validated five-point Dutch lan-
guage version [12]. The items of the FFI-5pt are identical to
those of the FFI but are rated on a five-point visual rating
scale ranging from “never” (0) to “always” [4] on the
Limitation scale, “no pain” (0) to “intense pain” [4] on the
Pain scale, and “no difficulty” (0) to “impossible” [4]o n
the Disability scale. To calculate the definitive scale scores,
the item scores are summed, divided by the maximum
possible sum of the item scores, and then multiplied by
100. The total score is the mean of the three scale scores
[12].
Statistical analysis The association between the signs,
symptoms, damage, and function parameters were calculat-
ed using Spearman’s correlation. Afterwards, we performed
regression analysis in order to assess the most important
variables that predict the functional outcome (HAQ) in our
model. For the data analysis, we used the Statistical
Package for the Social Sciences (SPSS 16.0).
Results
Thirty patients were included, of whom 25 were female.
The mean age was 54 years, and median disease duration
was 8 years. Twenty had a positive rheumatoid factor. The
1476 Clin Rheumatol (2011) 30:1475–1479median HAQ DI was 1.18, and Larsen and Sharp/van der
Heijde scores were 1.0 and 4.0, respectively.
Table 1 presents Spearman’s correlation coefficients of
the correlation between clinical signs and function. Clinical
signs were the presence of either swelling or pain as a sign
of joint inflammation. Pain and swelling of the ankle
showed weak but statistically significant correlation coef-
ficients between 0.273 and 0.293 with limitation and
disability, measured on the 5-FFI, as well as with the
HAQ and the mobility subscale of the AIMS. The clinical
signs of the forefoot joints did not correlate with any of the
functional outcome measures. Of the ultrasound (US)
parameters, only PDUS of the hindfoot showed a weak
but statistically significant correlation with the HAQ
walking.
In Table 2,w ep r e s e n tt h eS p e a r m a n ’s correlation
coefficients between structural damage and function. Both
the Larsen and the Sharp/van der Heijde showed a
statistically significant correlation (rs=0.263 and 0.277,
respectively) with the total HAQ DI. Further, the Larsen
score correlated with the 5-FFI limitation subscale (rs=
0.282). There was a moderate negative correlation between
the JAM and 5-FFI pain (rs=−0.325). The JAM did not
correlate significantly with any of the other functional
measures. Swelling of the MTPs showed a negative
correlation (rs=−0.516) with disease duration. All measures
of structural damage as well as the total HAQ DI correlated
moderate with disease duration: JAM (rs=−0.584), SvdH
(rs=0.660), (Larsen rs=0.470), and HAQ DI (rs=0.470).
None of the 5FFI subscales correlated with disease
duration.
Regression model
We searched for the variables explaining the variance in the
total HAQ DI. The following variables were entered:
disease duration, 5-FFI total pain score, swelling ankle,
US synovitis total score, and the SvdH score. These
variables were entered on basis of their correlation
coefficient (>0.3) or they were judged as important
predictors of the HAQ in earlier studies [13]. Using the
enter method, a significant model emerged (F=21.316, p<
0.001). Sixty-four percent of the variance in HAQ DI score
is explained by the following variables: disease duration, 5-
FFI pain subscale, and swelling of the ankle. The regression
coefficients with the 95% CI are presented in Table 3.
Discussion
In this study, we explored associations between clinical
signs and symptoms, structural damage, and function in
connection with disease duration and the contribution of the
individual foot segments.
Our data suggest that impaired foot function is associ-
ated more with signs and symptoms of the ankle than with
forefoot complaints. Function of the foot is only weakly
associated with overall radiological damage but again with
a larger impact of the hindfoot. Finally, disease duration
influences damage and function as well.
When regarding clinical signs in relation to function, we
found that the results of our observational cross-sectional
study are partially in line with earlier studies. In our study,
pain and swelling of the ankle correlated weakly but
statistically significantly with function, whereas forefoot
symptoms did not. These findings confirm earlier studies
suggesting that subjective pain of the forefoot does not
correlate with function [14] and that patients considered
their ankle complaints more impactful than forefoot
complaints [1]. The ultimate function of the feet, walking,
is severely and more impaired by rear foot disease than by
forefoot involvement [15].
Regarding the relation between radiological damage and
function, we found that both the Larsen and the Sharp/van
der Heijde score correlated weakly with the HAQ DI but
fell out of the regression model. The Larsen score
correlated with the 5-FFI-limitation subscale, this is in line
with preceding studies, which showed that general joint
damage is correlated with loss of function [4, 13, 16].
Furthermore, there was a weak correlation between the
Table 1 Spearman’s correlations coefficients (p value) between clinical signs/symptoms and function
Pain ankle Swelling ankle Pain MTPs/toes Swelling MTPs US PD MTPs US PD hind foot
5-FFI limitation 0.273 (0.034) 0.290 (0.025) −0.200 (0.126) −0.166 (0.206) −0.045 (0.734) 0.127 (0.334)
5-FFI pain 0.095 (0.470) 0.010 (0.940) −0.049 (0.710) −0.027 (0.836) 0.176 (0.178) 0.025 (0.851)
5-FFI disability 0.293 (0.023) 0.278 (0.032) −0.248 (0.056) −0.168 (0.200) 0.019 (0.885) 0.023 (0.860)
HAQ walking 0.098 (0.455) 0.104 (0.428) −0.234 (0.071) −0.189 (0.147) 0.167 (0.203) 0.374 (0.003)
Total HAQ 0.053 (0.689) 0.353 (0.006) −0.133 (0.309) −0.073 (0.579) 0.169 (0.196) 0.112 (0.396)
AIMS mobility level 0.257 (0.047) 0.286 (0.027) −0.02 (0.882) −0.029 (0.824) 0.005 (0.967) 0.142 (0.280)
5-FFI Five Foot Function Index, HAQ Health Assessment Questionnaire, AIMS Arthritis Impact Measurement Scales, US PD ultrasound power
Doppler, MTPs metatarsophalangeals
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the 5-FFI-limitation subscale, which may reflect the
seriousness of destruction of the hindfoot and ankle.
With disease duration, function (HAQ) also worsened.
The triangle of increasing radiological damage, worsening
function with longer disease duration has been described by
many others, varying from stable progression rate [17]t oa
steeper worsening, but earlier plateau [18]. Belt et al.
concluded that after 20 years of follow-up, the subtalar joint
and ankle were affected in 24 of the 103 patients but
leading to severe impairment [19]. The JAM, presented as a
measure of joint deformity, also correlates with disease
duration in our rather established RA cohort. In an early
RA population, one might imagine that the JAM predom-
inantly reflects disease activity and would not show a
relationship with disease duration. Swelling of the MTPs
correlated negatively with disease duration. This might
reflect the treatment effect and among others is shown in
the study of Welsing et al. [20].
In the regression analysis, we found that disease
duration, pain, and swelling of the ankle were the only
significant predictors of the HAQ DI. This is in line with
other studies, which report pain as one of the most
important predictors of the HAQ DI followed by disease
activity and radiographic damage [21, 22]. Most large
cohort studies report a significant predictive value for
radiographic damage on the HAQ DI. The lack of
significance in our cohort might possibly be explained by
the fact that we only used the Sharp/van der Heijde and
Larsen scores of the foot and ankle, scores of the hands and
large joints were not included. In most studies, the Sharp/
van der Heijde score is not specified. Hulsmans et al.
demonstrated that approximately half of the Sharp/van der
Heijde score could be attributed to the damage of the feet.
Extrapolating this to our current data, one might assume
that the correlations regarding radiographic damage would
have been larger [17]. Moreover, the total number of
patients in this study was only small.
Although lately more interest in the foot in RA arises,
we still think that the subject is somewhat neglected. It is
illustrative that in the DAS 28, the most widely used
instrument to measure disease activity in RA, the feet are
not included, sometimes leading to an invalid definition of
remission in individuals [23]. This may not only lead to
insensitive scoring on population level (in the case of
research) but also to the neglect of foot inflammation or
damage, especially where we sense a tendency towards
more strategy (DAS 28) driven care [24–26]. Within the
rheumatic foot, most attention is focussed on the joints of
the forefoot. However, our study supports the idea that
involvement of the hindfoot and ankle may contribute to
impairment and disability in the same way as the forefoot
as has been suggested earlier [1, 15].
A limitation of this study is the small number of patients
studied, which limits the ability to find strong correlations,
but despite the small number and weak correlations, we
found some significant correlations indicating the existence
of true relationships. Another drawback is that the cross-
Table 2 Spearman’s correlations coefficients (p value) between radiographic damage/limitation and function
SvdH Larsen JAM feet US er HF US er FF
5-FFI limitation 0.190 (0.154) 0.282 (0.032) 0.163 (0.212) 0.135 (0.303) 0.263 (0.046)
5-FFI pain −0.054 (0.689) 0.051 (0.702) −0.325 (0.011) −0.149 (0.255) −0.164 (0.210)
5-FFI disability 0.002 (0.991) 0.195 (0.142) −0.080 (0.541) 0.106 (0.422) −0.033 (0.801)
HAQ walking 0.001 (0.993) 0.242 (0.067) 0.047 (0.724) 0.137 (0.295) 0.177 (0.175)
Total HAQ 0.277 (0.035) 0.263 (0.046) 0.194 (0.138) 0.073 (0.582) 0.165 (0.208)
AIMS mobility level 0.134 (0.314) 0.162 (0.226) −0.06 (0.648) 0.072 (0.587) 0.173 (0.187)
5-FFI Five Foot Function Index, HAQ Health Assessment Questionnaire, AIMS Arthritis Impact Measurement Scales, SvdH Sharp/van der Heijde,
JAM Joint Alignment Motion Scale, US er HF Ultrasound Erosion Score Hindfeet, US er FF ultrasound erosion score forefeet
95% CI of the regression coefficient
Model Regression coefficients Lower bound Upper bound p value
(Constant) −0.401 0.310 0.798
Disease duration 0.478 0.001 0.003 0.000
FFI 5 total pain score 0.545 0.012 0.023 0.000
Swelling ankle 0.281 0.140 0.521 0.001
US synovitis total score 0.118 −0.013 0.071 0.176
SvdH total score 0.068 −0.005 0.011 0.428
Table 3 Regression analysis
with HAQ DI as the dependent
variable
Standardized coefficients (b)
and their CI, adjusted R
2 0.64
FFI Foot Function Index, US
ultrasound, SvdH Sharp/van der
Heijde, CI confidence interval
1478 Clin Rheumatol (2011) 30:1475–1479sectional design obstructs conclusions regarding time
relations. However, cross-sectional studies, including
patients with a broad range of disease durations, seem to
provide fairly reliable estimates of the course of health
outcomes [27]. Future research should focus longitudinally
on the relation between clinical signs and structural damage
of the foot and especially the ankle.
In conclusion, we suggest that in RA patients, pain and
swelling of the ankle contribute more to disability than
forefoot signs. In daily clinical practice and clinical
research, rheumatologists should pay attention to the ankle
and hindfoot as well as they contribute to disability.
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